Existence of pattern 5 on radical prostatectomy: Poor prognostic factor associated with a lower biochemical recurrence-free survival

被引:0
作者
Pastori, J. [1 ,2 ]
Balssa, L. [1 ,2 ]
Lillaz, J. [3 ]
Guichard, G. [1 ]
Chabannes, E. [1 ]
Bernardini, S. [1 ]
Bittard, H. [1 ,2 ]
Thiery-Vuillemin, A. [2 ,4 ,5 ]
Kleinclauss, F. [1 ,2 ,5 ]
机构
[1] CHRU Besancon, Ser Urol & Transplantat Renale, F-25003 Besancon, France
[2] Univ Franche Comte, F-25000 Besancon, France
[3] CHI Haute Saone, Serv Urol, F-25000 Vesout, France
[4] CHRU Besancon, Serv Oncol Med, F-25000 Besancon, France
[5] Inserm, UMR 1098, F-25000 Besancon, France
来源
PROGRES EN UROLOGIE | 2014年 / 24卷 / 07期
关键词
Oncological outcomes; Prostate Cancer; Radical prostatectomy; Gleason pattern 5; Adverse pathological factors; GLEASON GRADE; CANCER;
D O I
10.1016/j.purol.2014.03.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. - To analyze the impact of the existence of Gleason grade 5 on the adverse pathology and biochemical recurrence-free survival of patients. Patients. - Three hundred and seventy-two prostatectomies were performed between 1999 and 2011 in our institution for localised prostate adenocarcinoma. We examined the existence of grade 5 of the specimen to determine the reliability of prostate biopsies in the diagnosis of grade 5 and the association of grade 5 with other histoprognostic factors. Biochemical recurrence-free survival was analyzed according to the presence of grade Sin the final specimen. Results. - In total, all histological data and biochemical recurrence-free survival were available for 321 patients who were included in the study. Sixty-eight had Gleason grade 5 (majority or third minority pattern) on the specimen while 253 had not. Grade 5, rarely diagnosed on biopsy (sensitivity = 26.47%) was correlated independently with the extracapsular extension (OR = 2.1; CI 95 [1.1-3.9]), the seminal vesicle invasion (OR = 3.8; CI 95 [1.7-8.7]) and positive surgical margins (OR = 2.0; CI 95 [1.1-3.6]). Overall survival was similar in both groups but the biochemical recurrence-free survival was statistically lower in the presence of grade 5 (HR = 3.7; CI 95 [1.8-7.6]). Biochemical recurrence-free survival was not different than grade 5 is predominant or third minority pattern (HR = 1.01; CI 95 [0.3-2.8]). On multivariate analysis, grade 5 was an independent risk factor for biochemical recurrence (P = 0.005) as well as seminal vesicle invasion (P = 0.047). Conclusion. - The existence of grade Sin the surgical specimen whatever the percentage was a poor prognostic factor associated with increased tumor aggressiveness and reduced biochemical recurrence-free survival. (C) 2014 Published by Elsevier Masson SAS.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 50 条
[41]   Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival [J].
Turker, Polat ;
Bas, Emine ;
Bozkurt, Suheyla ;
Gunlusoy, Bulent ;
Sezgin, Arsenal ;
Postaci, Hakan ;
Turkeri, Levent .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (01) :93-98
[42]   Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer [J].
Chun, Felix K. -H. ;
Graefen, Markus ;
Zacharias, Mario ;
Haese, Alexander ;
Steuber, Thomas ;
Schlomm, Thorsten ;
Karakiewicz, Pierre I. ;
Huland, Hartwig .
WORLD JOURNAL OF UROLOGY, 2006, 24 (03) :273-280
[43]   Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer [J].
Xu, Ning ;
Chen, Hui-Jun ;
Chen, Shao-Hao ;
Xue, Xue-Yi ;
Chen, Hong ;
Zheng, Qing-Shui ;
Wei, Yong ;
Li, Xiao-Dong ;
Huang, Jin-Bei ;
Cai, Hai ;
Sun, Xiong-Lin .
ONCOTARGET, 2016, 7 (41) :67476-67484
[44]   Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer [J].
Felix K.-H. Chun ;
Markus Graefen ;
Mario Zacharias ;
Alexander Haese ;
Thomas Steuber ;
Thorsten Schlomm ;
Jochen Walz ;
Pierre I. Karakiewicz ;
Hartwig Huland .
World Journal of Urology, 2006, 24 :273-280
[45]   Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy [J].
Goltz, Diane ;
Gevensleben, Heidrun ;
Dietrich, Joern ;
Ellinger, Joerg ;
Landsberg, Jennifer ;
Kristiansen, Glen ;
Dietrich, Dimo .
ONCOIMMUNOLOGY, 2016, 5 (10)
[46]   CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients [J].
Meller, Sebastian ;
Zipfel, Lisa ;
Gevensleben, Heidrun ;
Dietrich, Joern ;
Ellinger, Joerg ;
Majores, Michael ;
Stein, Johannes ;
Sailer, Verena ;
Jung, Maria ;
Kristiansen, Glen ;
Dietrich, Dimo .
EPIGENETICS, 2016, 11 (12) :871-880
[47]   RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung [J].
Kim, Yujin ;
Jin, DongHao ;
Lee, Bo Bin ;
Cho, Eun Yoon ;
Han, Joungho ;
Shim, Young Mog ;
Kim, Duk-Hwan .
CLINICAL EPIGENETICS, 2015, 7 :7-32
[48]   Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy? [J].
Sokoll, Lori J. ;
Zhang, Zhen ;
Chan, Daniel W. ;
Reese, Adam C. ;
Bivalacqua, Trinity J. ;
Partin, Alan W. ;
Walsh, Patrick C. .
JOURNAL OF UROLOGY, 2016, 195 (02) :330-336
[49]   Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease [J].
Diniz, Clarissa P. ;
Landis, Patricia ;
Carter, H. Ballentine ;
Epstein, Jonathan I. ;
Mamawala, Mufaddal .
JOURNAL OF UROLOGY, 2017, 198 (03) :608-613
[50]   Impact of Gleason score on biochemical recurrence free survival after radical prostatectomy with positive surgical margins [J].
Roux, V. ;
Eyraud, R. ;
Brureau, L. ;
Gourtaud, G. ;
Senechal, C. ;
Fofana, M. ;
Blanchet, P. .
PROGRES EN UROLOGIE, 2017, 27 (8-9) :467-473